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Abstract  
Objectives. This study measured gender differences in Prader-Willi syndrome (PWS) in 
regards to the severity of behavioural symptoms. Methods. The Food Related Problem 
Questionnaire (FRPQ), the Aberrant Behavior Checklist Japanese Version, the Childhood 
Routines Inventory, the Pervasive Developmental Disorders Autism Society Japan Rating 
Scale, and Japanese ADHD-RS were administered to PWS patients (45 males ages 6 to 58 
and 37 females ages 6 to 45). To examine the effects that gender and genotype have on the 
severity of each symptom, two-way ANOVAs were conducted. Results. Significant 
interactions were found only in regards to FRPQ scores, such as FRPQ total score (F(1, 
78)=8.43, p<0.01). The FRPQ of male deletion (DEL) individuals was higher than those of 
female DEL, and male mUPD. The FRPQ of male maternal uniparental disomy (mUPD) was 
lower than that of female mUPD. Conclusions. In terms of problem behaviors, routines, 
autistic behaviors, and hyperactivity, no significant differences were found. Food-related 
behaviours in DEL were more severe in males, although those in mUPD were less severe in 
males.  
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1. Introduction 
Prader-Willi syndrome (PWS) is a genetic disorder caused by a loss of expression of the 
paternally derived genes on chromosome 15q11-13. The causes of this disruption include a 
paternal deletion (DEL) of 15q11-13, and maternal uniparental disomy 15 (mUPD; when both 
copies of chromosome 15 are maternally inherited) [1]. As a neurodevelopmental disorder, PWS 
is associated with neonatal hypotonia, hypogonadism, hyperphagia, progressive obesity, and 
mild to moderate mental retardation [2]. The physical manifestations of PWS include short 
stature, small hands and feet, hypopigmentation, and craniofacial anomalies. Based on 
epidemiological surveys, the birth rate is estimated at around 1 in 25,000 [3].  
The behavioural manifestations of this syndrome include hyperphagia [4, 5], temper 
tantrums [6], obsessive-compulsive behaviors [7, 8], repetitive and ritualistic behavior [9], 
self-injurious behavior [10, 11], autistic behaviors [12, 13], hyperactive/impulsive behaviors 
[14, 15], and psychiatric disorders [16]. Due to lack of specific drugs in controlling PWS-related 
behaviors, pharmacological treatment should only be used with caution and in combination with 
behavioural management and psychiatric support [17].  
In terms of population prevalence for people with Prader-Willy syndrome, the gender ratio 
is close to 1:1 [1, 18, 19, 20], including non-Western countries [21]. So far, however, there has 
been little research into gender differences in individuals with PWS in relation to behavioural 
symptom severity. One piece of data was presented by Dykens [22], who found females are more 
inclined to pick their skin than males. Such gender difference in terms of skin picking was also 
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found in individuals with non-specific mental retardation [23]. When food-related behaviors 
were analyzed by both gender and genotype, female mUPD patients were found to be less 
severely affected than female DEL patients in terms of length of gavage feeding and a later onset 
of hyperphagia. This difference between mUPD and DEL was not found in male patients [24]. 
Aside from Prader-Willi syndrome, certain mental disorders show marked gender 
differences in the diagnosis rates. For example, unipolar depression is twice as common in 
women. In contrast, the prevalence of alcohol dependence is more than twice as high in men than 
in women [25]. The diagnosis of anti-social personality disorder is more than three times as high 
in men than in women. On the other hand, severe mental disorders such as schizophrenia and 
bipolar disorder are associated with no pronounced gender differences in terms of the prevalence 
rate [25]. Among neurodevelopmental disorders, autism spectrum disorders (ASD) have a 
consistent male predominance ranging from 2.5:1 to 4:1 in individuals with autistic disorder and 
9:1 in individuals with Asperger disorder [26, 27, 28]. Attention deficit hyperactivity disorder 
(ADHD) is more commonly diagnosed in males than females, with male-to-female ratios 
ranging from 4:1 to 9:1 [29]. Eating disorders, which is one of the most important psychiatric 
categories to the behavioural aspects of PWS, are more common among females than males in 
both, anorexia nervosa and bulimia nervosa [30, 31]. Equally important is the fact that the 
reverse pattern of gender disparity is found in “subthreshold binge eating disorder” (0.6% 
women and 1.9% men) and that roughly comparable gender distribution is observed in the 
prevalence of “any binge eating” in women (4.9%) and men (4.0%) [32].  
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In terms of problems behavior in individuals with non-PWS mental retardation findings 
regarding gender differences in Williams syndrome have been divided. Leyfer et al. [33], 
Pérez-García et al. [34] and Klein-Tasman et al.[35] did not find gender differences in 
psychiatric and problem behaviors. However, Porter et al. [36] found greater externalizing, 
somatic, affective, and conduct problems in girls. Also, Dykens [37] found that fearfulness was 
higher for girls than for boys. In the Down syndrome sample, problem behaviour was more 
prevalent in boys, than girls [38]. By contrast, psychosis was predominantly seen in females with 
Down syndrome [39]. 
This study aims to explore gender differences in PWS in regards to the severity of 
behavioural symptoms. There are three inherent advantages in this study. Firstly, this is the only 
study of its kind in regards to gender differences in behavioural aspects of PWS, based on a large 
sample of the rare genetic disorder. Secondly, all subjects were recruited from a single institution 
and confirmed genetically with PWS using fluorescence in situ hybridization or the methylation 
test. Thirdly, all subjects with PWS were assessed by a single clinical psychologist (H.O.). 
Hence, the psychometrical data of this study can avoid the risk of inter-rater variability caused by 
participants being assessed by multiple assessors. At the same time, it should be noted that this 
single-center study has not only strength, but also weakness, because of sample selection bias 
and a small sample size.   
 
2. Subjects and Methods 
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This study started upon receiving approval from the ethics committee of Dokkyo Medical 
University Koshigaya Hospital with which the authors were affiliated. After obtaining informed 
consent, the neurocognitive and behavioural assessment of each participant was carried out.  
 
2.1 Subjects. Participants were 82 Japanese individuals with PWS recruited from a single 
location. The Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital was 
used for this purpose. All patients were diagnosed with PWS using fluorescence in situ 
hybridization or the methylation test. The participants consisted of 45 males (ages 6 to 58) and 
37 females (ages 6 to 45), including 34 males and 25 females confirmed as having a DEL 
involving 15q11-13, and 11 males and 12 females confirmed as having mUPD of chromosome 
15 (Table 1). Psychotropic medications were prescribed to 16 out of 45 males and 9 out of 37 
females.  
TABLE 1  Patient Characteristics 
 Total Male Female DEL mUPD p-value (t-test)  
      Gender groups Genotype groups 
Number (patients) 82 45 37 59 23   
IQ (mean±SD) 49.3±9.6 49.9±9.3 48.2±10.3 49.7±9.8 44.6±6.5 0.44 0.001* 
IQ range 39－84 39－79 39－84 39－84 39－62   
Age (mean±SD) 18.6±9.4 19.7±10.2 16.9±8.0 19.0±9.5 15.4±7.6 0.11 0.017* 
Age range 6－58 6－58 6－45 6－58 6－36   
 
2.2 Methods. The assessment of behavior 
An extended battery of behavioural assessment was employed. In all cases, the psychologist 
(H.O.) involved in collecting data was blind to the genetic status of each patient.  
2.3. Measures.  
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2.3.1. Intellectual ability. To measure intellectual ability, a Japanese version of the Wechsler 
Intelligence Scale [40, 41, 42, 43] was administered.  
2.3.2. Food-related behaviours. To assess the severity of food-related behaviors, the Food 
Related Problem Questionnaire (FRPQ) was administered. This is an informant-based 
questionnaire to assess eating behaviors in people with PWS, consisting of 16 items, with three 
subscales (preoccupation with food (P), impairment of satiety (S) and other food-related 
negative behaviors (N)). Examples of the questions are: ‘How often does the person compare the 
size or content of their meal with others?’ (P); ‘After a normal sized meal, how often does the 
person say they still feel hungry?’ (S); and ‘If given the opportunity, how often would the person 
‘help themselves’ to food which they should not have?’ (N). As Russell and Oliver [44] 
presented, the FRPQ has sufficiently robust psychometric properties to appraise the food-related 
problems in individuals with PWS.  
2.3.3. Aberrant behaviours. To assess the degree of problem behaviors in individuals with PWS, 
the Aberrant Behavior Checklist Japanese Version (ABC-J) [45] was applied. It is a 58 item 
checklist which takes about 10-15 minutes to complete. There are five subscales: a) irritability 
and agitation, b) lethargy and social withdrawal, c)stereotypic behavior, d) hyperactivity and 
noncompliance, and e) inappropriate speech. It was found that the ABC identifies salient features 
of mental illness in individuals with mental retardation [46], including autism spectrum disorder 
[47], and is an effective tool in measuring treatment response [46, 48].  
2.3.4. Routine behaviours. To measure the extent of routines, the Childhood Routines Inventory 
 7 
(CRI) was administered. This is a parent-report checklist of commonly occurring children’s 
routines [49], consisting of 19 items, including 5 items for ‘just right behavior’ and 5 items for 
‘repetitive behavior’. An example of the former is “Prefers to have things done in a particular 
order”, and that of the latter is “Prefers the same household schedules or routines”. It was found 
that the CRI is an effective tool in measuring the severity of routine behaviors in normal young 
children [49] and children with Down syndrome [50].  
2.3.5. Autistic symptomatology. Autistic symptomatology was assessed using the Pervasive 
Developmental Disorders Autism Society Japan Rating Scale (PARS) [51, 52]. This scale is a 
behavior checklist, developed as a screening questionnaire to determine pervasive 
developmental disorders (PDDs). When assessing adolescents and adults, 33 items for 
adolescents, partially shared by those for children, are applied for the evaluation of current 
autistic states. The PARS for adolescents is made up to five clinical subscores consisting of 
interpersonal skills (6 items), communication (7 items), obsession (6 items), problematic 
behaviors (11 items) and hypersensitivity (3 items). 
2.3.6. Inattention and hyperactivity/impulsivity. The Japanese ADHD-RS [53] was administered 
to all participants. The ADHD-RS [54] obtains parent ratings regarding the frequency of each 
ADHD symptom based on DSM-IV criteria. The scale consists of 2 subscales: inattention (9 
items) and hyperactivity/impulsivity (9 items). Parents are asked to state the degree to which 
they best describe the child’s behavior over the previous 6 months. All items are scored on a 
4-point Likert scale from 0 (‘rarely or never’), to 3 (‘always or very often’), with higher scores 
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reflecting higher degree of inattention and hyperactivity/impulsivity. The reliability and the 
validity of the Japanese ADHD-RS have already been established [53].   
By means of a numerical coding system, all data were guarded under strict confidentiality 
and anonymity. The data were analyzed by SPSS 20.0J for Windows. The results are expressed 
as mean (s.d. and range). To examine the effect that gender and genotype have on the severity of 
behavioural symptoms, two-way analyses of variance (ANOVAs) were conducted. The two 
gender groups (male versus female) and the two genotypes of PWS (DEL and mUPD) were used 
as independent variables, and the behavioural scores were used as dependent variables.  
 
3. Results 
As Table 1 shows, the mean IQs in both males and females were slightly less than 50, with no 
statistical difference between both groups. These scores are more than 50 points under the 
normative population score of 100, indicating a considerable impairment in intellectual abilities. 
As far as genotypes are concerned, a statistically significant difference was found between DEL 
and mUPD, with higher scores in the DEL group [15, 55].  
Table 2 shows the results in regards to the degree of behavioural symptoms of PWS 
individuals. In order to examine that genders and genotypes have on the symptom’s severity, 
two-way ANOVAs were conducted. Two gender groups and the two genotypes of PWS were 
used as independent variables, and the scores of the FRPQ, the ABC-J, the CRI, the PARS, and 
the ADHD-RS were used as dependent variables.  
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Statistically significant interactions between genders and genotypes were found only in 
regards to FRPQ scores: FRPQ total score (F(1, 78)=8.43, p<0.01), FRPQ-P (F(1, 78)=6.66, 
p<0.05), FRPQ-S (F(1, 78)=7.74, p<0.01), and FRPQ-N (F(1, 78)=4.04, p<0.05). On finding 
this, a Bonferroni procedure was performed to test the simple main effects.  
In terms of the FRPQ total score, it was found that the score of male DEL was higher than 
that of female DEL (F(1, 78)=4.22, p<0.05), on the contrary, the score of male mUPD was lower 
than that of female mUPD (F(1, 78)=4.56, p<0.05). Besides, the FRPQ score of male DEL was 
found to be higher than that of male mUPD (F(1, 78)=17.43, p<0.01).  
In regards to the FRPQ subscores, the FRPQ-P (preoccupation) score of male DEL was 
higher than that of male mUPD (F(1, 78)=8.79, p<0.01). The FRPQ-S (Satiety) score of male 
DEL was higher than that of female DEL (F(1, 78)=4.43, p<0.05), and was higher than that of 
male mUPD (F(1, 78)=11.32, p<0.01). The FRPQ-N (Negativity) score of male DEL was higher 
than that of male mUPD (F(1, 78)=15.84, p<0.01) (Figure 1).  
TABLE 2  The FRPQ, ABCJ, CRI, PARS, ADHD-RS scores and the Results of Two-Way ANOVA Using the Two Gender Groups and the Two Genotypes 
  Gender  Genotype  ANOVA 
interaction 
 
 Total Male Female DEL mUPD F P 
FRPQ total 34.4±15.0 35.6±15.3 33.0±14.8 37.3±14.6 27.0±13.6 8.43 0.005* 
FRPQ-P 9.3±4.4 9.5±4.5 9.0±4.3 9.8±4.4 8.0±4.2 6.66 0.012* 
FRPQ-S 15.4±6.3 16.0±6.1 14.8±6.5 16.3±6.1 13.3±6.3 7.74 0.007* 
FRPQ-N 9.7±6.9 10.1±7.1 9.2±6.7 11.3±6.8 5.7±5.3 4.04 0.048* 
ABCJ total 33.2±29.4 34.3±30.8 31.8±27.9 30.7±27.0 39.8±35.2 0.91 0.344 
ABCJ excitement 11.3±10.2 12.0±10.2 10.4±10.2 11.2±10.1 11.6±0.6 1.20 0.277 
ABCJ apathy 7.1±8.0 6.6±7.3 7.7±8.9 5.8±6.3 10.6±10.7 2.16 0.145 
ABCJ stereotype 2.1±3.2 1.9±2.9 2.3±3.6 1.7±2.7 3.2±4.2 0.93 0.337 
ABCJ hyperactivity 8.6±9.2 9.5±10.6 7.4±7.1 8.1±8.7 9.9±10.7 0.06 0.812 
ABCJ inappropriate 4.0±3.2 4.2±3.2 3.8±3.3 4.0±3.3 4.2±3.0 0.27 0.603 
CRI total 3.1±1.6 2.8±1.5 3.3±1.8 3.1±1.7 2.9±1.6 0.38 0.542 
CRI Fre 9.3±5.8 8.0±5.1 10.7±6.2 9.7±5.8 8.5±5.8 0.84 0.364 
CRI Jr 0.8±0.8 0.8±0.9 0.7±0.8 0.9±0.7 0.5±1.0 0.85 0.363 
CRI JrFre 2.1±2.6 2.2±2.8 2.1±2.5 2.3±2.0 1.7±3.6 0.51 0.480 
CRI Re 0.7±0.6 0.6±0.6 0.8±0.7 0.7±0.7 0.8±0.6 0.16 0.687 
CRI ReFre 2.1±2.1 1.5±1.5 2.7±2.5 2.1±2.3 2.2±1.8 0.03 0.868 
PARS child 9.8±7.0 10.2±7.7 9.2±5.5 9.4±6.6 11.3±8.0 0.00 0.972 
PARS adolescent and adult  17.0±9.2 16.9±9.4 17.2±9.2 15.9±9.1 21.6±8.8 1.06 0.307 
ADHD-RS total 4.9±5.9 5.3±6.7 4.1±3.8 4.6±5.7 5.7±6.6 0.02 0.902 
ADHD-RS inattention 2.9±3.4 3.1±3.8 2.5±2.3 2.7±3.0 3.5±4.3 0.02 0.877 
ADHD-RS 
hyperactivity/impulsivity 
2.0±3.1 2.2±3.5 1.5±2.2 1.9±3.3 2.3±2.5 0.16 0.687 
*p<0.05 
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FRPQ: Food Related Problem Questionnaire; FRPQ-P: preoccupation with food, S: impairment of satiety, -N: composite negative behavior; ABC-J: Aberrant Behavior 
Checklist-Community Japan Rating Scale; CRI: Childfood Routine Inventory; CRI Jr: just right behaviours, Re: repetitive behavious, Fre: frequency/intensity score; 
PARS: Pervasive Developmental Disorders Autism Society Japan Rating Scale; ADHD-RS: ADHD Rating Scale.  
 
FIGURE 1 The effect of gender (male vs. female) and genotype (DEL vs. UPD) of PWS on the total score and preoccupation (P), impairment of 
satiety (S), and composite negative behavior (N) domains of FRPQ. 
  
  
 
4. Discussion 
To our knowledge, this study is the first attempt to compare a wide range of behavioural features 
of PWS between male and female groups. To examine the effect that genotypes as well as 
genders have on the severity of behavioural symptoms, two-way analyses of variance 
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(ANOVAs) were conducted. Two gender groups and two genotypes of PWS were used as 
independent variables. Apart from food-related behaviors, no significant statistical differences 
were found between male and female in regards to other behavioural features, such as problem 
behaviors, routines, autistic symptoms, inattention, and hyperactivity. As a whole, male and 
female PWS patients seem to be more similar than different regarding PWS-related behavioural 
symptoms. In this respect, our data accord with previous reports, which found similarities, rather 
than differences, in behavior between male and female [56, 57, 58].  
The two-way ANOVAs to examine the interaction between gender and genotype, followed 
by the Bonferroni procedure to test the simple main effects, showed the following: food-related 
behaviors of male DEL were more severe than those of female DEL, and on the contrary 
food-related behaviors of male mUPD were less severe than those of female mUPD. Thus, the 
reverse pattern of gender disparity between the two genotypes was found.  
These data contradicted the recent report of Jauregi et al. [58], who found female dominant 
scores in only two among the twenty-two items of the Developmental Behavior Checklist for 
Adults: ‘irritability’ and ‘distress over small changes in their routine or environment’. Aside 
from these items, they did not find significant differences between male and female behaviors. 
At the same time, they found significant differences between DEL and non-DEL, such as 
 12 
‘increase in appetite’ with a higher score in DEL. Indeed, Dykens et al. [59] showed the lack of 
significant relations between food-related behaviors and genetic status. However, as the results 
suggest, the relationship between hyperphagia and genotype may be complicated by gender 
disparity. There seems to be a need for further investigation in terms of the impact of the gender 
differences on the relationship between genetic status, hyperphagia, and other behavioural 
symptoms.  
It is evident that further methodological limitations exist in this study. First, the impact of 
biological changes in chronological adolescence was not considered. Unfortunately, the number 
of patients enrolled in this study was too small to analyze gender differences in the behavioural 
data in multiple age groups.  According to Ogata et al. [15], there is a growing tendency for the 
autistic and impulsive behavioural problems, which are more severe in mUPD than in DEL that 
can manifest themselves later in adolescence. Likewise, gender differences in the behavioural 
symptom severity should take age, as well as genotypes into consideration.  
Second, this study did not encompass the entire range of psychiatric disorders relevant to 
gender differences in PWS. For example, it remains to be seen in regards to clinical categories 
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whose rate is known to show striking gender differences. They include male-dominant disorders, 
such as alcohol dependence and anti-social personality disorder, and female-dominant ones, 
such as depression, anxiety, and somatic complaints [25]. Moreover, this study did not cover 
affective and psychotic disorders, in spite of the fact that the PWS group was known to have 
higher rates of affective disorders with psychotic features [60]. Although little is known about 
gender differences, PWS individuals with a psychotic disorder showed a disproportionate 
number of mUPD [61]. A more comprehensive study is required to illuminate gender differences 
in the severity of various psychiatric categories in PWS.  
Third, a future study should assess the influence of endocrinological factors including 
growth hormone therapy and diabetes on the behavioural aspects with PWS focusing on gender 
differences. Based on 35 Brazilian patients with PWS, Quaio et al. [62] demonstrated that 
growth hormone treatment considerably improved the control of weight gain and body mass 
index for female patients, but no effect on either parameters in male patients. They suggested that 
in male patients the benefits of growth hormone treatment may have been overcome by other 
factors, such as food-intake behaviors. The relationship between the gender differences in the 
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effects of growth hormone treatment and those in food-related behaviors is an area worthy of 
further exploration, because it could potentially throw a new light on the possibility of 
gender-specific hormonal treatment to PWS. Aside from food-related behaviors, another 
gender-specific hormonal treatment was conducted by Kido et al. [63]. They found testosterone 
replacement therapy improved secondary sexual characteristics and body composition without 
adverse behavioural problems in male patients with PWS. Finally, due to a single-institution 
study that aimed at a rare genetic disorder, the size of sample is relatively small. For this reason, 
the male-female similarity regarding PWS-related behaviors in this study should be interpreted 
with caution.  
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